Gujarat Kidney & Super Speciality Ltd Q4 FY2025-2026 Results: Summary

Revenue
₹31.29Cr
Net Profits
₹5.04Cr
Net Profit Margins
16.11%
Highlights
Revenue:

Gujarat Kidney & Super Speciality Ltd’s revenue jumped 218.31% since last year same period to ₹31.29Cr in the Q4 2025-2026. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated 34.23% jump in its revenue since last 3-months.

Net Profits:

Gujarat Kidney & Super Speciality Ltd’s net profit jumped 293.75% since last year same period to ₹5.04Cr in the Q4 2025-2026. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated 71.43% jump in its net profits since last 3-months.

Net Profit Margins:

Gujarat Kidney & Super Speciality Ltd’s net profit margin jumped 23.7% since last year same period to 16.11% in the Q4 2025-2026. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated 27.71% jumped in its net profit margins since last 3-months.

FAQs

What was the revenue for Gujarat Kidney & Super Speciality Ltd in Q4 results 2025?

The revenue for Gujarat Kidney & Super Speciality Ltd in the Q4 results 2025 was ₹31.29Cr.

What was the net profit for Gujarat Kidney & Super Speciality Ltd in Q4 results 2025?

The net profit for Gujarat Kidney & Super Speciality Ltd in the Q4 results 2025 was ₹5.04Cr.

What was the net profit margin for Gujarat Kidney & Super Speciality Ltd in Q4 results 2025?

The net profit margin for Gujarat Kidney & Super Speciality Ltd in the Q4 results 2025 was 16.11%.

What was the revenue for Gujarat Kidney & Super Speciality Ltd in Q4 results 2024?

The revenue for Gujarat Kidney & Super Speciality Ltd in the Q4 results 2024 was ₹9.83Cr.

What was the net profit for Gujarat Kidney & Super Speciality Ltd in Q4 results 2024?

The net profit for Gujarat Kidney & Super Speciality Ltd in the Q4 results 2024 was ₹1.28Cr.

What was the net profit margin for Gujarat Kidney & Super Speciality Ltd in Q4 results 2024?

The net profit margin for Gujarat Kidney & Super Speciality Ltd in the Q4 results 2024 was 13.02%.